Role of Atorvastatin on Endothelial Function in Patients with Dyslipidemia
DOI:
https://doi.org/10.9734/bpi/etdhr/v1/15055DKeywords:
Atorvastatin, total cholesterol, low-density lipoproteins, flow-mediated dilatation, intima -media thicknessAbstract
Background: The prevalence and mortality rates of coronary artery disease have been known to be higher in the last decade.
Objectives: This study presents a correlation between flow-mediated dilatation (FMD), total cholesterol (TC), and low-density lipoproteins (LDL) in patients with dyslipidemia that are not treated with any hypolipemiant medication (DYS-STAT) vs. dyslipidemia patients treated with atorvastatin (DYS+STAT) to assess the effect of atorvastatin on FMD.
Results indicated a higher prevalence of increased LDL and TC values in the DYS-STAT group vs. DYS+STAT group. Also, the decreased values of FMD were found in DYS-STAT group vs. DYS+STAT group.
Conclusion: Our study suggests the improvement of endothelial function in dyslipidemia patients treated with atorvastatin.